FDA approves first factor XIa stroke drug - Quiz - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

FDA approves first factor XIa stroke drug

In a 12,327-patient trial, asundexian cut recurrent ischemic stroke risk by 26% alongside antiplatelets.

  • By

  • Mouj Hijazi

  • November 10, 2026

  • 3 min

Share

Original Source(s)

FDA approves first factor XIa stroke drug

  • by Mouj Hijazi

  • November 10, 2026

Related Content

Hyperacute Interleukin-1β Production and Neutrophil Extracellular Trap Formation in the Cerebral Circulation of Stroke Patients with Large Vessel Occlusion

Covert macrovascular disease and early outcome after ischemic cerebrovascular events

Performance and usability of retrieval-augmented large language models for stroke patient and caregiver support